Rigel Pharmaceuticals Ownership | Who Owns Rigel Pharmaceuticals?
Rigel Pharmaceuticals Ownership Summary
Rigel Pharmaceuticals is owned by 88.13% institutional investors, 3.07% insiders, and 8.81% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 9.83% of RIGL shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 4.27% of its assets in Rigel Pharmaceuticals shares.
RIGL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Rigel Pharmaceuticals | 88.13% | 3.07% | 8.81% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 1.77M | 9.83% | $47.83M |
| Armistice capital | 1.28M | 7.12% | $34.61M |
| State street | 1.12M | 6.23% | $30.29M |
| Vanguard group | 1.04M | 5.76% | $44.48M |
| Acadian asset management | 666.43K | 3.71% | $18.01M |
| Lsv asset management | 601.51K | 3.34% | $16.27M |
| Marshall wace, llp | 598.38K | 3.33% | $16.18M |
| Capitolis liquid global markets | 591.55K | 3.31% | $16.76M |
| American century companies | 544.43K | 3.03% | $14.72M |
| D. e. shaw | 445.68K | 2.48% | $12.05M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Cm management | 235.00K | 5.31% | $6.35M |
| Globeflex capital l p | 217.84K | 0.89% | $5.89M |
| Empire financial management company | 76.44K | 0.71% | $3.27M |
| Armistice capital | 1.28M | 0.62% | $34.61M |
| Watershed asset management | 16.39K | 0.46% | $443.05K |
| Range financial group | 39.50K | 0.36% | $1.07M |
| Pharvision advisers | 20.52K | 0.33% | $581.39K |
| Opaleye management | 70.00K | 0.25% | $1.89M |
| Inspire investing | 63.89K | 0.14% | $1.73M |
| Capitolis liquid global markets | 591.55K | 0.13% | $16.76M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | 1.28M | 0.62% | 444.00K |
| American century companies | 544.43K | 0.01% | 289.94K |
| Acadian asset management | 666.43K | 0.03% | 172.82K |
| Two sigma investments, lp | 405.81K | 0.01% | 134.58K |
| Vanguard fiduciary trust | 124.01K | 0.00% | 124.01K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | - | - | -14.80M |
| Nuveen asset management | - | - | -3.22M |
| Healthcare of ontario pension plan trust fund | - | - | -1.36M |
| Stonepine capital management | - | - | -1.04M |
| Soleus capital management | 10.00K | 0.01% | -290.03K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 124.01K | 0.00% | 124.01K | $3.35M |
| Burney co/ | 91.68K | 0.08% | 91.68K | $2.48M |
| Empowered funds | 82.62K | 0.01% | 82.62K | $2.23M |
| Axa investment managers | 32.59K | 0.00% | 32.59K | $923.39K |
| Vanguard global advisers | 25.81K | 0.00% | 25.81K | $697.98K |
Sold Out
| Holder | Change |
|---|---|
| Srs capital advisors | -1.00 |
| Financial consulate | -10.00 |
| Synergy asset management | -15.00 |
| Strategic investment solutions, inc. /il | -25.00 |
| Daiwa securities group | -40.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 152 | -20.42% | 15,851,405 | -1.52% | 88 | 1.11% | 84 | -24.32% | 43 | -30.65% |
| Dec 31, 2025 | 45 | -73.53% | 2,395,282 | -84.02% | 13 | 0.19% | 33 | -68.27% | 9 | -80.43% |
| Sep 30, 2025 | 48 | -61.29% | 2,467,259 | -82.23% | 13 | 0.23% | 24 | -61.90% | 14 | -61.11% |
| Jun 30, 2025 | 123 | 0.82% | 13,882,606 | -0.14% | 77 | 1.27% | 62 | -3.13% | 36 | -5.26% |
| Mar 31, 2025 | 3 | -97.60% | 1,156,951 | -90.41% | 6 | 0.14% | 1 | -98.78% | 1 | -95.24% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 790.00K | 4.27% | -7.80K |
| Vanguard US Total Market Shares ETF | 548.78K | 3.07% | - |
| Avantis US Small Cap Value ETF | 548.48K | 2.96% | - |
| Vanguard Total Stock Mkt Idx Inv | 542.05K | 2.93% | - |
| iShares Russell 2000 ETF | 421.65K | 2.28% | 3.57K |
| SPDR® S&P Biotech ETF | 223.01K | 1.24% | 500.00 |
| Nuveen Quant Small Cap Equity R6 | 213.85K | 1.16% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 205.46K | 1.11% | 972.00 |
| GS Glb Sm Cp CORE Eq Base Inc USD Close | 197.11K | 1.07% | -93.07K |
| GS Global SmallCap CORE Eq Base USD | 197.11K | 1.07% | -51.03K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 26, 2026 | Ali-Jackson Kamil | - | Sell | $72.92K |
| Feb 20, 2026 | MOOS WALTER H | - | Sell | $145.44K |
| Feb 04, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $42.60K |
| Feb 05, 2025 | Schorno Dean L | EVP & Chief Financial Officer | Sell | $38.02K |
| Feb 04, 2025 | Santos David A | EVP, Chief Commercial Officer | Sell | $44.46K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2026 Q1 | - | 1 |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
RIGL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools